Apotex Seeks Stay In Plavix Suit Pending USPTO Ruling

By Jocelyn Allison

Law360, New York (January 11, 2010, 2:41 PM ET) -- Apotex Inc. is asking a federal court to stay its long-running patent suit with Sanofi-Aventis SA over the blood-thinning drug Plavix while the U.S. Patent and Trademark Office re-examines Sanofi's patent for the drug.

The generic drugmaker filed the motion for stay Friday in the U.S. District Court for the Southern District of New York and offered to post a $442.2 million bond for damages should the result come out in Sanofi's favor.

Apotex lost a bid in November to take the dispute to the U.S....
To view the full article, take a free trial now.

Already a subscriber? Click here to login

You must correct or enter the following before you can submit this form:

All fields required

  5. Required

Only Law360 gives you:

Non-stop coverage of high-stakes litigation across 30 practices

Real-time tracking and reports on 10,000+ companies, firms and industries

Over 80,000 attorney profiles with neutral data collected from active lawsuits

Research tools to find cases, court documents, attorneys and companies

Customized feeds and alerts that can easily be shared with colleagues

In-depth expert analysis from high-profile attorneys at top firms

Access to our vault with over 75,000 original articles